Presentation is loading. Please wait.

Presentation is loading. Please wait.

Distribution of Cardiovascular Risk Factors by Baseline CRP Concentration M. Cushman et al. Circulation. 2005;112:25-31.

Published byBeate Gjertsen Modified over 5 years ago

Similar presentations

Presentation on theme: "Distribution of Cardiovascular Risk Factors by Baseline CRP Concentration M. Cushman et al. Circulation. 2005;112:25-31."— Presentation transcript:

1 Distribution of Cardiovascular Risk Factors by Baseline CRP Concentration
M. Cushman et al. Circulation. 2005;112:25-31

2 Cumulative rate of MI or CHD death, data for men
M. Cushman et al. Circulation. 2005;112:25-31

3 Cumulative rate of MI or CHD death, data for women
M. Cushman et al. Circulation. 2005;112:25-31

4 Incidence rate per 1000 person-years of MI or CHD death by baseline CRP
M. Cushman et al. Circulation. 2005;112:25-31

5 Association of Baseline CRP With Incident MI or CHD Death Over 10 Years
M. Cushman et al. Circulation. 2005;112:25-31

6 Relative Risk of CHD for CRP >3 mg/L Compared With <1 mg/L by Categories of Baseline Risk Factors M. Cushman et al. Circulation. 2005;112:25-31

7 Incidence rates per 1000 person-years of first MI or CHD death by baseline CRP, stratified by sex and presence of subclinical atherosclerosis M. Cushman et al. Circulation. 2005;112:25-31

8 Ten-year rate of CHD according to baseline CRP and 10-year predicted risk from the Framingham Risk Score Data for men M. Cushman et al. Circulation. 2005;112:25-31

9 Ten-year rate of CHD according to baseline CRP and 10-year predicted risk from the Framingham Risk Score Data for women M. Cushman et al. Circulation. 2005;112:25-31

Download ppt "Distribution of Cardiovascular Risk Factors by Baseline CRP Concentration M. Cushman et al. Circulation. 2005;112:25-31."

Similar presentations

Nonsense Mutations in PCSK9 and Cardiovascular Risk Factors among 3363 Black Participants in the Study Jonathan C.Cohen, et al, N Engl J Med 2006;354:1264-72.

Nonsense Mutations in PCSK9 and Cardiovascular Risk Factors among 3363 Black Participants in the Study Jonathan C.Cohen, et al, N Engl J Med 2006;354:
1 Severity of illness (APACHE II score ≥ 25) stratified by RIFLE category in septic shock 28.3 45.2 58.6 69.9 0 10 20 30 40 50 60 70 80 NoneRiskInjuryFailure.

1 Severity of illness (APACHE II score ≥ 25) stratified by RIFLE category in septic shock NoneRiskInjuryFailure.
Slide Source: Lipids Online Slide Library www.lipidsonline.org Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE IT): Design Cannon CP.

Slide Source: Lipids Online Slide Library Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE IT): Design Cannon CP.
HYPERLIPIDAEMIA. 4S 4444 patients –Hx angina or MI –Cholesterol 5.5-8.0 Simvastatin 20mg (10-40) vs. placebo FU 5 years  total cholesterol 25%;  LDL.

HYPERLIPIDAEMIA. 4S 4444 patients –Hx angina or MI –Cholesterol Simvastatin 20mg (10-40) vs. placebo FU 5 years  total cholesterol 25%;  LDL.
Frank B. Hu et al N Engl J Med 2004; 351: 2694- 703 Body-Mass Index and Relative Risk of Death from All Causes during 24 Years of Follow-up.

Frank B. Hu et al N Engl J Med 2004; 351: Body-Mass Index and Relative Risk of Death from All Causes during 24 Years of Follow-up.
Characteristics of 3921 Men Seen by a Primary Care Provider Steven A. Grover, et al, Arch Intern Med. 2005;166:213-219.

Characteristics of 3921 Men Seen by a Primary Care Provider Steven A. Grover, et al, Arch Intern Med. 2005;166:
Baseline Characteristics of Individuals From the General Population by Quartiles of Triglyceride Levels a Børge G. Nordestgaard, et al. JAMA 2007;298:299-308.

Baseline Characteristics of Individuals From the General Population by Quartiles of Triglyceride Levels a Børge G. Nordestgaard, et al. JAMA 2007;298:
Pai JK et al. N Engl J Med 2004; 351:2599-2610. Relative CHD risk by increasing baseline CRP plasma levels,* relative to CRP

Pai JK et al. N Engl J Med 2004; 351: Relative CHD risk by increasing baseline CRP plasma levels,* relative to CRP
Baseline Characteristics of Cases, Controls, and Entire VA-HIT Population James D. Otvos, et al, Circulation 2006;113:1556-1563.

Baseline Characteristics of Cases, Controls, and Entire VA-HIT Population James D. Otvos, et al, Circulation 2006;113:
Predictive Value of Coronary Calcium Scoring Matthew Budoff, MD, FACC, FAHA Associate Professor of Medicine UCLA School of Medicine Director, Cardiac CT.

Predictive Value of Coronary Calcium Scoring Matthew Budoff, MD, FACC, FAHA Associate Professor of Medicine UCLA School of Medicine Director, Cardiac CT.
VBWG Predictor of CV Events and Mortality in Postmenopausal Women: Leukocyte Count.

VBWG Predictor of CV Events and Mortality in Postmenopausal Women: Leukocyte Count.
Enrollment, Randomization, and Follow-up of Study Participants ADVANCE Collaborative Group. N Engl J Med 2008;358:2560-72.

Enrollment, Randomization, and Follow-up of Study Participants ADVANCE Collaborative Group. N Engl J Med 2008;358:
Slide Source: Lipids Online Slide Library www.lipidsonline.org LDL Cholesterol, mg/dL Years of Follow-up Ridker PM et al. N Engl J Med 2002;347:1557–1565.

Slide Source: Lipids Online Slide Library LDL Cholesterol, mg/dL Years of Follow-up Ridker PM et al. N Engl J Med 2002;347:1557–1565.
Coronary Artery Calcium

Coronary Artery Calcium
Participant Characteristics by Lowest Leg AAI Category Ann M. O’Hare, et al, Circulation 2006;113;388-393.

Participant Characteristics by Lowest Leg AAI Category Ann M. O’Hare, et al, Circulation 2006;113;
Slide Source: Lipids Online Slide Library www.lipidsonline.org C-Reactive Protein, Metabolic Syndrome, and Risk for CV Events: Women’s Health Study 14,719.

Slide Source: Lipids Online Slide Library C-Reactive Protein, Metabolic Syndrome, and Risk for CV Events: Women’s Health Study 14,719.
Ridker PM, et al. Lancet 2009;373:1175-82. Baseline clinical characteristics of the study population in the placebo and rosuvastatin groups according.

Ridker PM, et al. Lancet 2009;373: Baseline clinical characteristics of the study population in the placebo and rosuvastatin groups according.
Baseline Characteristics of 1994 of Men With Incident CHD (1994 to 2000) and Matched Control Subjects From the Health Professionals Follow-up Study T.

Baseline Characteristics of 1994 of Men With Incident CHD (1994 to 2000) and Matched Control Subjects From the Health Professionals Follow-up Study T.
Date of download: 6/3/2016 From: Elevated Plasma Homocysteine Level Is an Independent Predictor of Coronary Heart Disease Events in Patients with Type.

Date of download: 6/3/2016 From: Elevated Plasma Homocysteine Level Is an Independent Predictor of Coronary Heart Disease Events in Patients with Type.
Atherosclerosis quantification by ultrasound Henrik Sillesen MD, DMSc Chairman & professor Dept. Vascular Surgery, Rigshospitalet Univ. of Copenhagen,

Atherosclerosis quantification by ultrasound Henrik Sillesen MD, DMSc Chairman & professor Dept. Vascular Surgery, Rigshospitalet Univ. of Copenhagen,

Similar presentations

Ads by Google